Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Up – What’s Next?

Shares of Ono Pharmaceutical Co. (OTCMKTS:OPHLF) gapped up before the market opened on Monday . The stock had previously closed at $13.50, but opened at $14.90. Ono Pharmaceutical shares last traded at $14.90, with a volume of 701 shares traded.

Analysts Set New Price Targets

Separately, Zacks Research upgraded Ono Pharmaceutical to a “hold” rating in a research report on Friday, April 17th. One research analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has an average rating of “Hold”.

Ono Pharmaceutical Price Performance

The company has a debt-to-equity ratio of 0.10, a current ratio of 3.02 and a quick ratio of 2.56. The company has a 50-day simple moving average of $14.35 and a 200-day simple moving average of $14.61. The stock has a market cap of $7.00 billion, a PE ratio of 15.05 and a beta of 0.34.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., founded in 1717 and headquartered in Osaka, Japan, is a research‐based pharmaceutical company specializing in the discovery, development and marketing of innovative therapies. With origins as a traditional pharmacy, Ono has grown into a global biopharmaceutical entity focused on delivering new treatment options across several therapeutic areas, including oncology, immunology, cardiovascular and antiviral diseases. The company conducts comprehensive research programs spanning early drug discovery through to clinical development.

One of Ono’s most recognized products is the immune checkpoint inhibitor nivolumab, marketed in collaboration with Bristol-Myers Squibb under the trade name Opdivo.